CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Celator Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 12, 2022Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders3
Jul 24, 2019Lyophilized Liposomes2
Nov 15, 2017Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders2

Top competitors of Celator Pharmaceuticals

Top competitors of Celator Pharmaceuticals based on patent oppositions.